Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Christina Wei, MD

City of Hope National Medical Center

Presented by K and J Road To a Cure in honor of Kerry O’Riordan McAdam and Jacquie Reynolds Beck

Hepatic natural killer cell dysregulation facilitates breast cancer liver metastasis

Robert Weinberg, PhD

Whitehead Institute for Biomedical Research

Mechanisms of Acquired Adaptation of Disseminated Breast Cancer Cells

Danny Welch, PhD

The University of Kansas Medical Center

Presented by Sister Sojourn in honor of Brandi Darr

Mitochondrial tRNA Fragments as Modifiers of Metastasis

Danny Welch, PhD

University of Kansas Cancer Center

Presented In Memory of Valerie Wright by Northwest Arkansas Metsquerade

New inhibitors of breast cancer metastasis

Danny Welch, PhD

University of Kansas Medical Center Research Institute

Presented by The Pittsburgh Metsquerade in honor of members: Jill Griffin, Andrea Dimond, Lori Czyzewski, and Sophia Holland

Mitochondrial Modifiers of Metastasis

Danny Welch, PhD

University of Kansas Medical Center Research Institute, Inc.

Presented by #Cancerland in Memory of Champagne Joy

BMRS1 MSD: A potential new inhibitor of breast cancer metastasis

Danny Welch, PhD

University of Kansas Cancer Center

KISS1 prevents seeded cancer cells from growing into full blown metastases

Alana Welm, PhD

University of Utah

Presented by 2020 New York Fashion Week in Memory of Halli Lannan

FORESEE: Functional precision oncology for metastatic breast cancer: a feasibility trial

Alana Welm, PhD

Test the value of tumorgrafts in predicting response to therapy.

MICHAEL WENDT, PhD

Purdue University

Enhancing anti-metastatic immunity through targeted inhibition of SHP2 phosphatase

MICHAEL WENDT, PhD

Purdue University Center for Cancer Research

Targeting Growth-Factor Receptor Discordant Metastatic Breast Cancer

Jennifer Wenzel, PhD, MS

Johns Hopkins University School of Nursing, School of Medicine (Oncology)

Presented by METAvivor Facebook Fundraisers in honor of all people living with MBC

Metastatic Treatment Decision Navigation: A Community Health Worker Model to Support Black Breast Cancer Patients and Decision Partners